An Act relative to benzodiazepines and non-benzodiazepine hypnotics

This bill updates Massachusetts laws regarding benzodiazepines and non-benzodiazepine hypnotics to improve patient safety and informed decision-making. It requires pharmacists to include bolded warnings about long-term use risks on prescription labels and mandates that doctors obtain written informed consent from patients before prescribing these drugs. Additionally, the legislation limits refills to prescriptions for less than a ten-day supply and establishes a standardized process for safely discontinuing these medications to manage withdrawal symptoms. The law also directs the Department of Public Health to create educational materials for consumers and appoints a special commission to study safe discontinuation protocols.